Bryan Kirby, MD
Pain Medicine · Carrollton, GANPI 1518183789
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,164 of the $6,608 with a category attached, or 78.1%. It is spread thinly across 36 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations.
Across 188 payments — averaging $35.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Medtronic$884
- Abbott$787
- Boston Scientific$418
- Nevro Corp.$370
- SPR Therapeutics, Inc$347
- plus $3K from 30 others
What the payments were for
- Travel & lodging$1,08816%
- Food & beverage$5,16478%
- Education$3565%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 9 | $1,229 |
| Medtronic | 18 | $884 |
| Abbott | 25 | $787 |
| Boston Scientific | 8 | $418 |
| Nevro Corp. | 18 | $370 |
| SPR Therapeutics, Inc | 7 | $347 |
| Globus Medical | 9 | $256 |
| Vertos Medical, Inc. | 8 | $214 |
| Dynasplint Systems Inc. | 1 | $195 |
| Collegium Pharmaceutical, Inc. | 10 | $185 |
| Pacira Therapeutics, Inc. | 11 | $169 |
| AbbVie | 7 | $166 |
| Vertex | 7 | $145 |
| Medical Device Business Services, Inc. | 1 | $137 |
| MML US, Inc. | 1 | $134 |
| Amgen | 8 | $127 |
| Heron Therapeutics, Inc. | 4 | $123 |
| Pacira Pharmaceuticals Incorporated | 4 | $111 |
| Biodelivery Sciences International, Inc. | 3 | $86 |
| Zimmer Biomet | 3 | $74 |
| Saluda Medical Americas, Inc. | 3 | $68 |
| Tersera Therapeutics LLC | 3 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| Avanos Medical | 2 | $33 |
| MDD US Operations, LLC | 2 | $32 |
| Johnson & Johnson | 1 | $29 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Medline Industries LP | 1 | $22 |
| Si-bone, Inc. | 1 | $18 |
| Merck | 1 | $14 |
| Acera Surgical, Inc. | 1 | $14 |
| Curonix LLC | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Heraeus Medical, LLC. | 1 | $13 |
| Polarityte, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$828
- INTELLIS ADAPTIVESTIM$402
- ETERNA$207
- Dynasplint$195
- INSIGNIA$173
- SPRINT PNS System$149
- Accurian$138
- STRATAFIX$137
- ReActiv8$134
- Proclaim IPG$103
How this compares
$6,608 in reported general payments places this provider in the 75th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 112 | $98,312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,115 | $22,022 |
| OxycontinOxycodone Hcl | 24 | $19,859 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 802 | $19,378 |
| Buprenorphine | 29 | $8,899 |
| Gabapentin | 590 | $7,421 |
| Oxycodone Hcl | 340 | $6,783 |
| ButransBuprenorphine | 11 | $5,938 |
| Duloxetine Hcl | 319 | $5,014 |
| Pregabalin | 236 | $4,350 |
| Hydromorphone Hcl | 168 | $2,394 |
| Baclofen | 211 | $2,386 |
| Celecoxib | 96 | $1,967 |
| Tramadol Hcl | 361 | $1,955 |
| Cyclobenzaprine Hcl | 155 | $1,312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $185 | $98,312112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Carrollton
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Susheel DuaAtlanta$36K
- Subodh AgrawalAthens$34K
- Jose MathewLawrenceville$27K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
- Ankur PatelGainesville$21K
- Margaret RisoGainesville$19K
- Steven HanlingAugusta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.